Metraipolis › archive › dc_a78cb4a2febd

Anemia correction using Roxadustat among MHD patients: 50mg versus 100mg dosing schedules — Europe PMC PMID:42145397

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42145397
DOI
10.6026/973206300221606
License (as archived)
solo-consultazione
Archived
2026-11-03T15:12:43.503Z
SHA-256 of the archived text
48fec63a7d3058c2c8d247f973c937bfec5760affea86c9b6beb51ae7839ed34
Stable URL of this page
https://metraipolis.com/documento/dc_a78cb4a2febd

How to cite

Anemia correction using Roxadustat among MHD patients: 50mg versus 100mg dosing schedules — Europe PMC PMID:42145397 — Europe PMC (en), https://europepmc.org/article/MED/42145397 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a78cb4a2febd (Metraipolis archive dc_a78cb4a2febd, sha256 48fec63a7d3058c2c8d247f973c937bfec5760affea86c9b6beb51ae7839ed34)
BibTeX
@misc{dca78cb4a2febd,
  title = {Anemia correction using Roxadustat among MHD patients: 50mg versus 100mg dosing schedules — Europe PMC PMID:42145397},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42145397},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a78cb4a2febd; sha256 48fec63a7d3058c2c8d247f973c937bfec5760affea86c9b6beb51ae7839ed34},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42145397. Agents can read the archived copy with the MCP tool read_document.